Synchronní bilaterální testikulární tumor ze zárodečných buněk: kazuistika a přehled literatury
Authors:
B. Detti 1; S. Scoccianti 1; S. Cassani 1; C. Franzese 1; V. Di Cataldo 1; D. Villari 2; T. Cai 3; I. Desideri 1; L. Livi 1; A. Lapini 4; G. Nicita 2; M. Carini 4; G. Biti 1
Authors‘ workplace:
Radioterapia, Azienda Ospedaliero‑Universitaria Careggi, Florence, Italy
1; Clinica Urologica II, University of Florence, Florence, Italy
2; Department of Urology, Santa Chiara Hospital, Trento, Italy
3; Clinica Urologica I, University of Florence, Florence, Italy
4
Published in:
Klin Onkol 2013; 26(4): 281-285
Category:
Case Report
Autoři deklarují, že v souvislosti s předmětem studie nemají žádné komerční zájmy.
Redakční rada potvrzuje, že rukopis práce splnil ICMJE kritéria pro publikace zasílané do bi omedicínských časopisů.
Obdrženo: 8. 1. 2013
Přijato: 3. 3. 2013
Overview
Tento článek popisuje případ 30letého muže s anamnézou jednostranného kryptorchidizmu, postiženého synchronním tumorem varlete. Pacient podstoupil chirurgickou resekci a následně adjuvantní radioterapii na oblast paraaortálních a ilických lymfatických uzlin. Pacienti se synchronní duplicitou jsou zpravida diagnostikováni ve vyšším stadiu onemocnění, nicméně prognóza u nich zůstává podobně příznívá jako u pacientů s jednostranným postižením.
Klíčová slova:
bilaterální seminom – kryptorchizmus – radioterapie – testikulární rakovina – nádor ze zárodečných buněk
Sources
1. Patel SR, Richardson RL, Kyols L. Synchronous and methacronous bilateral testicular tumors: Mayo Clinic experience. Cancer 1990; 65(1): 1– 4.
2. Coogan CL, Foster RS, Simmons GR et al. Bilateral testicular tumors: management and outcome in 21 patients. Cancer 1998; 83(3): 547– 552.
3. Theodore C, Terrier‑ Lacombe MJ, Laplanche A et al. Bilateral germ‑ cell tumours: 22‑year experience at the Institut Gustave Roussy. Br J Cancer 2004; 90(1): 55– 59.
4. Che M, Tamboli P, Ro JY et al. Bilateral testicular germ cell tumors: twenty‑year experience at M.D. Anderson Cancer Center. Cancer 2002; 95(6): 1228– 1233.
5. Garner MJ, Turner MC, Ghadirian P et al. Epidemiology of testicular cencer: an overview. Int J Cancer 2005; 116 (3): 331– 339.
6. García MA, Gutiérrez GJD, Ortiz LGE et al. Synchronous bilateral testicular seminoma in an adult patient with bilateral cryptorchidism: a case report and literature review. Actas Urol Esp 2010; 34(2): 210– 211.
7. Gilbert JB, Hamilton JB. Studies in malignant tumors of the testis. IV. bilateral testicular cancer. Incidence, nature, and bearing upon management of the patient with a single testicular cancer. Cancer Res 1942; 2: 125– 129.
8. Aristizabal S, Davis JR, Miller RC et al. Bilateral primary germ cell testicular tumors: report of four cases and review of the literature. Cancer 1978; 42(2): 591– 597.
9. Holzbeierlein JM, Sogani PC, Sheinfeld J. Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001. J Urol 2003; 169(6): 2122– 2125.
10. Kanetsky PA, Mitra N, Vardhanabhuti S et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet 2009; 41(7): 811– 815.
11. Korkola JE, Houldsworth J, Feldman DR et al. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. J Clin Oncol 2009; 27(31): 5240– 5247.
12. Morales‑Barrera R, Valverde C, Rodón J et al. Bilateral testicular germ cell tumours: a single hospital experience. Clin Transl Oncol 2010; 12(4): 299– 302.
13. Richie JP. Simultaneous bilateral tumors with unorthodox management. World J Urol 1984; 2: 74.
14. Heidenreich A, Weissbach L, Höltl W et al. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001; 166(6): 2161– 2165.
15. Klatte T, De Martino M, Arensmeier K et al. Management and outcome of bilateral testicular germ cell tumors: a 25‑year single center experience. Int J Urol 2008; 15(9): 821– 826.
16. Tekin A, Aygun YC, Aki FT et al. Bilateral germ cell cancer of the testis: a report of 11 patients with a long‑term follow‑up. BJU Int 2000; 85(7): 864– 868.
17. Tomita E, Kondo T, Nakazawa H et al. Successful testis preservation for bilateral testicular tumors with a new chemotherapy‑based protocol: initial results of three cases. Int J Urol 2007; 14(9): 879– 882.
18. van Basten JP, Hoekstra HJ, van Driel MF et al. Cisplatin‑based chemotherapy changes the incidence of bilateral testicular cancer. Ann Surg Oncol 1997; 4(4): 342– 348.
19. Bokemeyer C, Schmoll HJ, Schöffski P et al. Bilateral testicular tumours: prevalence and clinical implications. Eur J Cancer 1993; 29A(6): 874– 876.
20. Oliver RT, Mason MD, Mead GM et al. Radiotherapy versus single‑dose carboplatin in adjuvant treatment of stage I seminoma: a randomized trial. Lancet 2005; 366(9482): 293– 300.
21. Pamenter B, De Bono JS, Brown IL et al. Bilateral testicular cancer: a preventable problem? Experience from a large cancer centre. BJU Int 2003; 92(1): 43– 46.
22. Garcia‑ del‑ Muro X, Maroto P, Gumà J et al. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study. J Clin Oncol 2008; 26(33): 5416– 5421.
23. Winter C, Albers P. Testicular germ cell tumors: pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 2011; 7(1): 43– 53.
24. Classen J, Schmidberger H, Meisner C et al. Radiotherapy for stages IIA/ B testicular seminoma: final report of a prospective multicenter clinical trial. J Clin Oncol 2003; 21(6): 1101– 1106.
25. Schmidberger H, Bamberg M, Meisner C et al. Radiotherapy in stage IIA and IIB tesicular seminoma with reduced portals: a prospective multicenter study. Int J Radiat Oncol Biol Phys 1997; 39(2): 321– 326.
26. Travis LB, Fossa SD, Schonfeld SJ et al. Second cancers among 40,576 testicular cancer patients: focus on long‑term survivors. J Natl Cancer Inst 2005; 97(18): 1354– 1365.
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2013 Issue 4
Most read in this issue
- Degradace proteinů ubikvitin‑proteazomovou dráhou
- Registr neuroendokrinních nádorů (NET) v ČR po třech letech sběru dat
- Současné trendy adjuvantní chemoterapie u nemalobuněčného karcinomu plic
- Karcinom pankreatu a faktory životního stylu